Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.
about
Cerebrospinal fluid biomarkers of Alzheimer’s diseaseThe Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate CancerDifferential denaturation of serum proteome reveals a significant amount of hidden information in complex mixtures of proteinsSmart surface for elution of protein-protein bound particles: nanonewton dielectrophoretic forces using atomic layer deposited oxidesWhat was old is new again: using the host response to diagnose infectious disease.Application of machine learning to proteomics data: classification and biomarker identification in postgenomics biology.Investigation of serum proteome alterations in human glioblastoma multiforme.Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection.Identification of urine biomarkers associated with lung adenocarcinoma.Facile synthesis of magnetic mesoporous hollow carbon microspheres for rapid capture of low-concentration peptides.Lanthanum silicate coated magnetic microspheres as a promising affinity material for phosphopeptide enrichment and identification.Proteomic investigation of falciparum and vivax malaria for identification of surrogate protein markers.Simultaneous extraction and rapid visualization of peptidomic and lipidomic body fluids fingerprints using mesoporous aluminosilicate and MALDI-TOF MS.Construction of a high-performance magnetic enzyme nanosystem for rapid tryptic digestionIdentification of Enolase 1 and Thrombospondin-1 as serum biomarkers in HBV hepatic fibrosis by proteomicsREPO4 (RE = La, Nd, Eu) affinity nanorods modified on a MALDI plate for rapid capture of target peptides from complex biosamples.The discovery and identification of a candidate proteomic biomarker of active tuberculosisCombined docking, molecular dynamics simulations and spectroscopic studies for the rational design of a dipeptide ligand for affinity chromatography separation of human serum albumin.Quantitative proteomic analysis of meningiomas for the identification of surrogate protein markers.Forward Look: Tenth Anniversary of the Human Genome Sequence and 21 Century Postgenomics Global Health - A Close Up on Africa and Women's Health.Biomarker discovery by novel sensors based on nanoproteomics approaches.Absolute quantification of DcR3 and GDF15 from human serum by LC-ESI MS.Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations.Proteomic technologies for the study of osteosarcomaRecent Advances on Luminescent Enhancement-Based Porous Silicon Biosensors.Weak cation exchange magnetic beads coupled with matrix-assisted laser desorption ionization-time of flight-mass spectrometry in screening serum protein markers in osteopenia.Serum proteome changes in dengue virus-infected patients from a dengue-endemic area of India: towards new molecular targets?Advances in the proteomic investigation of the cell secretome.The proteomics big challenge for biomarkers and new drug-targets discovery.Digital transplantation pathology: combining whole slide imaging, multiplex staining and automated image analysis.The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluidsSources of technical variability in quantitative LC-MS proteomics: human brain tissue sample analysisProteomic analysis of bronchoalveolar lavage fluid (BALF) from lung cancer patients using label-free mass spectrometry.Current advantages in the application of proteomics in inflammatory bowel disease.Interferometric silicon biochips for label and label-free DNA and protein microarrays.Update on the proteomics of major arthropod vectors of human and animal pathogens.Differential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures.The role of proteomics in understanding biological mechanisms of sepsis.Proteomic analysis of cerebrospinal fluid in California sea lions (Zalophus californianus) with domoic acid toxicosis identifies proteins associated with neurodegeneration.
P2860
Q22252572-E2864D0F-4D33-4149-9FE6-6B5B7E79FEAFQ26738703-88F7C5BB-D067-41FA-81D9-D330DD3E84CEQ28488743-21E91760-1AF9-469B-883B-D38A5E33AE7EQ28830310-834FE8F9-40E1-4F09-84C3-213F9F2CE201Q30376327-B727015D-6A12-43F3-925E-2887A63BF004Q30676067-25395FA5-E190-4ECD-A285-6CFB3454D4D9Q31063977-1ECFDE1A-D398-4503-ADE8-6ED30C16D17FQ33860793-5E963382-7859-4C1E-93C9-34540295C53CQ33888856-6626FB61-5F96-4530-A4AB-C85AF8D68798Q34050535-CD84B7F9-3A97-4FB6-AEA5-695E015CFB4CQ34313411-50A1B165-1894-463F-82B6-84687FB25555Q34388636-A6509941-50F0-47F7-97D8-53B176ADD48FQ34418701-A42E279A-BE4A-43C4-A321-7C28CCF5A433Q34460560-C9C88606-6E8F-4066-B41B-ED954DF91E46Q34812703-60CDA76F-9F12-44AB-9B20-E7518C8B8C3EQ34930216-6B547007-13D6-4BD4-BB83-A13EFBBF428AQ35028192-2EBF8D91-B49F-43FA-924E-4FF119EAA436Q35252046-25F5BE67-179D-4CF8-B66D-15EA4B178B2CQ35440783-DF1081C3-4943-44DB-A25E-269851B647E9Q35690458-344B9BB9-C75D-4E5C-AE18-A5EC05A24FE1Q35831485-233F9649-619F-4110-A7E1-22EF70033368Q35879535-4CF55A06-9B3D-456B-BFA4-CCC36D6A399FQ35880037-82DA8BB8-96AF-4F65-9AC6-4133216B5B24Q35897776-769D0D78-E4CE-4507-9B86-46810551D1F4Q35936196-4056BD1D-C89C-4E91-833C-447FC2043384Q36062140-33A2D6CF-6D53-4BEA-A4AA-6AA1F28BD66AQ36283254-34001CEC-2CBC-4DFA-BC26-AB3081052A2CQ36406560-8ABF9F28-2D69-4E63-9CBB-A1DEEC5871BDQ36432402-387C92F2-A8D7-4475-AC7B-3B3D33E8BB64Q36769130-3D9127D6-E20C-45D1-AB11-DBB4F87E41B4Q36771005-C2DD536B-B451-49CB-A96B-41FC6E38AC1CQ36889137-4C33FB59-9856-48F7-99C4-B84476400437Q36963132-DA7236F0-C553-4027-8FD8-03E2F34CFBADQ37710444-4BF8AF93-32A7-4AD8-AB23-6222483CCE23Q38022190-E4CB7D3C-120D-44B9-90AE-9C4963ED8E81Q38038828-8D513335-1AE4-4B32-BC38-537741699951Q38053132-7CF10C3F-DA41-43A6-9CDA-A3E2F67C9BDAQ38167708-2A006A9C-4D4F-42C2-A75D-50BB4086306FQ38171431-CD6BCBA7-009D-4831-A3DC-AE7664F7CCF1Q38403840-C92E1E77-2EBF-43F5-AD41-0CE60BC8B332
P2860
Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Proteomic technologies for the ...... advances and challenges ahead.
@ast
Proteomic technologies for the ...... advances and challenges ahead.
@en
type
label
Proteomic technologies for the ...... advances and challenges ahead.
@ast
Proteomic technologies for the ...... advances and challenges ahead.
@en
prefLabel
Proteomic technologies for the ...... advances and challenges ahead.
@ast
Proteomic technologies for the ...... advances and challenges ahead.
@en
P2093
P2860
P356
P1433
P1476
Proteomic technologies for the ...... advances and challenges ahead.
@en
P2093
Aliasgar Moiyadi
Kishore Gollapalli
Panga J Reddy
Rekha Jain
Sandipan Ray
Sanjeeva Srivastava
P2860
P304
P356
10.1002/PMIC.201000460
P577
2011-05-04T00:00:00Z